Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for January 2009
January 5, 2009
- Immutep Announces Positive Interim Results in Phase I/II Chemoimmunotherapy Trial in Breast Cancer
- Merck Serono: Study Published in JCO Shows Erbitux Enhances Efficacy in mCRC Patients with KRAS Wild-Type Tumors in 1st-Line Setting
- Discovery Labs' Surfaxin Phase 2 BPD Clinical Trial Results Published in Pediatrics
- Genmab Announces Interim Results in Pivotal Study of Zalutumumab in Head and Neck Cancer
- Inflammatory Factors May be Key to Controlling Diabetic Macular Edema
January 6, 2009
- Kythera Biopharmaceuticals Announces Positive Results from Two Phase 2 Studies with ATX-101 Demonstrating Reduction of Submental Fat
- Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice
- Acacia Pharma Completes Clinical Trial with APD 405 for Nausea & Vomiting
- Study Demonstrates that AHCC Enhances Immune System by Increasing the Production of Key Dendritic Cells
January 7, 2009
January 8, 2009
- ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
- Positive Results for Peplin's Phase IIb AK Trial
- Syntarga Demonstrates In Vivo Proof of Concept for its Antibody-Drug Conjugate Technology
- First Candidate from Scynexis' Novel Cyclophilin Inhibitor Platform, SCY-635, Establishes Proof of Concept in HCV-Infected Adults
- Juvaris BioTherapeutics Announces Positive Data from Clinical Trial of JVRS-100 Adjuvanted Flu Vaccine
- Altus Pharmaceuticals Successfully Completes Phase 1 Study of Long Acting Formulation of Recombinant Human Growth Hormone
- Why Bladder Cancer Is Deadlier for Some
January 9, 2009
- Study Finds More Effective Treatment for Pneumonia Following Influenza
- Orexigen Therapeutics Announces First of Four Phase 3 Trials of Contrave Meets Co-Primary and Key Secondary Endpoints
- RegeneRx Reports Phase II Pressure Ulcer Trial Results
- Gene Abnormality Found to Predict Childhood Leukemia Relapse
- New Malaria Drug May Meet Resistance Says Expert
January 12, 2009
- ARYx Therapeutics, Inc. Provides Additional Data on Atrial Fibrillation Clinical Trial on ATI-2042
- InterMune Reports Results from Triple Combination Study of ITMN-191
- Qnexa Treatment Results in Improved Glucose Control in Obese Non-Diabetic Subjects
- Repros Therapeutics Inc. Announces That Proellex Significantly Reduced Pain in a U.S. Phase 2 Clinical Trial in Women with Moderate to Severe Endometriosis
- Sunesis Pharmaceuticals Provides Year-End Clinical Update on Voreloxin
- InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
- Seventeen Months After Cord Blood Transplant - Child is Free of Signs of Cancer
January 13, 2009
- Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling
- Hana Biosciences Phase 1 Data On Menadione, Its Novel First-in-Class Compound for Treatment-Limiting Skin Toxicity Associated With EGFR Inhibitors, to be Presented At 33rd Hawaii Dermatology Seminar
- Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
- NeurogesX Announces Publication of Phase 3 Data for QUTENZA (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
- AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab Combination (ARX-03) in Treating Procedural Pain and Anxiety
- InNexus Biotechnology Completes Preclinical Study Confirming in Vivo Effectiveness and Safety of Lead Candidate DXL625, Schedules Meeting With FDA
- Cytos Biotechnology Presents Analysis of Patient Diaries Including Six Month Follow-up Data from Phase II Study with CYT003-QbG10 Monotherapy for the Treatment of Allergic Diseases
- Nymox Releases Positive New Clinical Trial Data on Durability of Response Rates to Company’s BPH Drug NX-1207
- Suven Participates at Biotech Showcase 2009
January 14, 2009
- New Overall Survival Study Results Confirm Oral Xeloda plus Oxaliplatin (XELOX) is Comparable to FOLFOX-4 for the First-Line Treatment of Advanced Colorectal Cancer
- RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments
- New Study First to Confirm Sandostatin LAR Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors
- Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer
- Merck KGaA: New Data Reinforce Consistent Efficacy Profile of Erbitux in First-Line mCRC Patients with KRAS Wild-Type Tumors
- Afinitor Phase II trial results positive in patients with advanced gastric cancer after failure of one or more prior treatments
- Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
- Mologen AG Announces Successful Course of Study of Cancer Drug MGN1703
- Half of Adults 50 and Younger With Low 10-Year Risk of CVD Have High Lifetime Risk
January 15, 2009
- Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
- Pegasys Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine
- New Tool Could Prevent Needless Stents and Save Money, Stanford Cardiologist Says
- Study Shows How Defective DNA Repair Triggers Two Neurological Diseases
- Neurotune Successfully Completes Phase 1 Trials with its Lead Compound NT-11624
- A Study In This Month's Journal Of Nervous And Mental Disease Reveals Hope For Recovery From Suicidal Thinking And Treatment Resistant Mental Illness
January 16, 2009
- Malaria: New Treatment is Upcoming
- ediGene: Presentation of Clinical Data Obtained with EndoTAG-1 for the Treatment of Pancreatic Cancer and with the Oncolytic Virus NV1020 for the Treatment of Metastasized Colorectal Carcinoma at the ASCO GI Meeting
January 20, 2009
- Rexin-G Shrinks Metastatic Tumors and Triples Survival Time in Chemotherapy-Resistant Pancreatic Cancer: Analysis of a U.S. Phase I/II Clinical Trial
- Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
- Unigene Reports Positive Results on a Novel Peptide for Reducing Food Consumption
- Chemoembolization Improving as Liver Cancer Treatment
January 21, 2009
- Aradigm Reports Positive Phase 2 Results with Inhaled Liposomal Ciprofloxacin Hydrochloride in Patients with Bronchiectasis
- Acusphere Announces Publication of Imagify Phase 3 Trials in the European Journal of Echocardiography
- Clinuvel: Positive Interim Phase III Results Announced for Unique Skin Protection Drug
- Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study
- Measurement of Kidney Function in Children with Kidney Disease Improved
- Alnylam and Collaborators at Harvard Medical School Demonstrate In Vivo Silencing of Key Genes Implicated in the Transmission of Herpes Simplex Virus-2 (HSV-2)
January 22, 2009
- ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
- Zevalin Produced 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital Lymphoma Study
- DiaKine Therapeutics Drug Improves Type 2 Insulin Action; Reduces Harm of Fat in Preclinical Study
- Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia
- Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss
- New Clinical Equation Accurately Measures Kidney Function in Children
January 23, 2009
- Hollis-Eden Researchers Present New Findings on Mechanism of Action for Anti-Cancer Drug Candidate Apoptone (HE3235)
- Oral Investigational Treatment Cladribine Tablets for Multiple Sclerosis Significantly Reduced Relapse Rate in Phase III Pivotal Trial
- Promedior's Fibrosis Program Featured at Keystone Symposia Conference
- VIRxSYS to Present at Phacilitate Cell & Gene Therapy Forum
- Onconova and DoD Collaborators Publish Research Demonstrating Increased Survivability of Previously Lethal Radiation in Mice with New Radioprotective Drug Ex-RAD
- Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29
- Novavax CMO to Present at Phacilitate Vaccine Forum Washington 2009
January 26, 2009
- University of California San Diego Researchers Present Preclinical Data Demonstrating Benefits of Triolex (HE3286) in Model of Obesity Induced Metabolic Disorders
- Access Pharmaceuticals Presents New Combination Data on the Company's Angiolix Therapeutic Monoclonal Antibody
- Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
January 27, 2009
- Circulation Publishes Pivotal Two-Year Results On Xience V Drug Eluting Stent
- Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
- EpiCept Announces Positive Results from Phase IIb Trial for EpiCept NP-1
- New Research Suggests Platelet 'Stickiness' May be the Single Most Important Risk Factor in Patients Treated with Coronary Stents - Findings May be Applicable to Anyone with Vascular Disease
January 28, 2009
- Pixantrone Increases Progression-Free Survival by 81% Compared to Standard Chemotherapeutic Agents in Phase III Trial
- St. Jude Finds More Than 100 Gene Variations Linked With Response to Leukemia Treatment
- Sociability Traced to Particular Region of Brain by Stanford Scientists
- PolyMedix to Present at Keystone Symposia Global Health Series Tuberculosis Biology, Pathology and Therapy
- Addex Successfully Completes ADX48621 Phase I Program
- AMT: Glybera Lowers Pancreatitis Incidence Significantly
- Support Cells, Not Neurons, Lull the Brain to Sleep
January 29, 2009
- New England Journal of Medicine Publishes Case Reports on the Investigational Use of Soliris (eculizumab) in Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
- Data from Columbia Laboratories' Study for the Prevention of Preterm Birth to be Presented at the Society for Maternal-Fetal Medicine (SMFM) 2009 Annual Meeting
- CombinatoRx Publishes Data on Selective Amplification of Synergistic Combination Drug Candidate
- Study Shows No Standardized Approach to Epidural Steroid Injections for Back Pain
- Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment
- Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief
January 30, 2009
- BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
- Cymbalta Significantly Reduced Osteoarthritis Knee Pain in New Study
- ImmuPharma PLC Lupuzor Phase IIb study
- King Pharmaceuticals Announces Positive Results from a 12-Month Open-Label Safety and Efficacy Study of Embeda Extended Release Capsules
- Effectiveness of Progesterone in Reducing Preterm Births May Be Altered by Genetic Predisposition
- Under-Treatment of Pain Exacerbated by Public Perceptions of Medicines and Safety
- Journal Article Reviews Research Using Oxycyte and PFCs in TBI and Decompression Sickness
- Cook Medical Unveils the Advance Drug-Eluting Balloon and Other Cutting-Edge Devices to Advance Leg Therapy
